Paul W Harms
Clinical Professor of Pathology
Clinical Professor of Dermatology and Program Associate
Pathology
[email protected]

Available to mentor
Paul W Harms
Clinical Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis.
      Ma F, Tsou P-S, Gharaee-Kermani M, Plazyo O, Xing X, Kirma J, Wasikowski R, Hile GA, Harms PW, Jiang Y, Xing E, Nakamura M, Ochocki D, Brodie WD, Pillai S, Maverakis E, Pellegrini M, Modlin RL, Varga J, Tsoi LC, Lafyatis R, Kahlenberg JM, Billi AC, Khanna D, Gudjonsson JE. Nat Commun, 2024 Jan 3; 15 (1): 210 DOI:10.1038/s41467-023-44645-6
      PMID: 38172207
    • Journal Article
      Squamoid Eccrine Ductal Carcinoma Displays Ultraviolet Mutations and Intermediate Gene Expression Relative to Squamous Cell Carcinoma, Microcystic Adnexal Carcinoma, and Porocarcinoma.
      Harms PW, Runge M, Chan MP, Liu C-J, Qin Z, Worden F, Robinson DR, Chinnaiyan AM, Mclean SA, Harms KL, Fullen DR, Patel RM, Andea AA, Udager AM. Mod Pathol, 2024 Aug 21; 37 (11): 100592 DOI:10.1016/j.modpat.2024.100592
      PMID: 39154783
    • Journal Article
      Development of a Multiplex Immunofluorescence Assay for Tumor Microenvironment Studies of Human and Murine Merkel Cell Carcinoma.
      Sun L, Verhaegen ME, McGue J, Olivei AC, Dlugosz AA, Frankel TL, Harms PW. Lab Invest, 2024 Aug 23; 104 (10): 102128 DOI:10.1016/j.labinv.2024.102128
      PMID: 39182611
    • Journal Article
      Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases.
      Kervarrec T, Westphal D, Pissaloux D, Legrand M, Tirode F, Neuhart A, Drouot F, Becker JC, Macagno N, Seris A, Jouary T, Beltzung F, Jullie M-L, Harms PW, Cribier B, Mourah S, Jouenne F, Fromont G, Louveau B, Mancini M, Kazakov DV, de la Fouchardière A, Battistella M. Histopathology, 2024 Oct; 85 (4): 566 - 578. DOI:10.1111/his.15214
      PMID: 38785043
    • Journal Article
      ERK hyperactivation in epidermal keratinocytes impairs intercellular adhesion and drives Grover disease pathology.
      Simpson CL, Tiwaa A, Zaver SA, Johnson CJ, Chu EY, Harms PW, Gudjonsson JE. JCI Insight, 2024 Sep 26; DOI:10.1172/jci.insight.182983
      PMID: 39325541
    • Journal Article
      Corrigendum to "Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma" [Neoplasia, Volume 21, Issue 3 (2019) 322-330].
      Choi JE, Verhaegen ME, Yazdani S, Malik R, Harms PW, Mangelberger D, Tien J, Cao X, Wang Y, Cieślik M, Gurkan J, Yazdani M, Jing X, Juckette K, Su F, Wang R, Zhou B, Apel IJ, Wang S, Dlugosz AA, Chinnaiyan AM. Neoplasia, 2024 Sep; 55: 101019 DOI:10.1016/j.neo.2024.101019
      PMID: 38943995
    • Journal Article
      Type I interferon governs immunometabolic checkpoints that coordinate inflammation during Staphylococcal infection.
      Reynolds MB, Klein B, McFadden MJ, Judge NK, Navarrete HE, Michmerhuizen BC, Awad D, Schultz TL, Harms PW, Zhang L, O'Meara TR, Sexton JZ, Lyssiotis CA, Kahlenberg JM, O'Riordan MX. Cell Rep, 2024 Aug 27; 43 (8): 114607 DOI:10.1016/j.celrep.2024.114607
      PMID: 39126652
    • Journal Article
      553 Dampening ERK hyper-activation rescues cell-cell adhesion in a model of Grover disease
      Tiwaa A, Zaver SA, Johnson CJ, Harms PW, Gudjonsson JE, Simpson CL. Journal of Investigative Dermatology, 2024 Aug; 144 (8): s97 DOI:10.1016/j.jid.2024.06.569